ARCUS BIOSCIENCES Trademark

Trademark Overview

On Wednesday, September 21, 2016, a trademark application was filed for ARCUS BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the ARCUS BIOSCIENCES trademark a serial number of 87178725. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 30, 2024. This trademark is owned by Arcus Biosciences, Inc.. The ARCUS BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of cancer immunotherapy; conducting clinical trials for others in the field of cancer immunotherapy
arcus biosciences

General Information

Serial Number87178725
Word MarkARCUS BIOSCIENCES
Filing DateWednesday, September 21, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 30, 2024
Registration Number5274568
Registration DateTuesday, August 29, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements

Certificate of Correction for RegistrationIn the statement, Column 1, line 6,"04/13/2015" should be deleted, and 04/01/2016 should be inserted.
Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and ServicesResearch and development services in the field of cancer immunotherapy; conducting clinical trials for others in the field of cancer immunotherapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 26, 2016
Primary Code042
First Use Anywhere DateFriday, April 1, 2016
First Use In Commerce DateFriday, April 1, 2016

Trademark Owner History

Party NameArcus Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameArcus Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHayward, CA 94545
Party NameArcus Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHayward, CA 94545

Trademark Events

Event DateEvent Description
Tuesday, January 30, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 30, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 9, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, August 29, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 25, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Wednesday, April 25, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 10, 2018TEAS SECTION 7 REQUEST RECEIVED
Tuesday, April 10, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 29, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2017NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2016ASSIGNED TO EXAMINER
Monday, September 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 24, 2016NEW APPLICATION ENTERED

Related Keywords

biosciences arcus immunotherapy field cancer trials others clinical conducting research development services